Immunoblotting and immunofluorescence showed that the addition of leptomycin B increased the nuclear fraction of KLLN at both 4 h and 16 h post-treatment in colon and breast cancer cell lines (Figure 2A and 2D, Supplementary Figure 2A–2D). Here, KLLN is linked to breast carcinoma.